Oculis Holding AG (OCS) Total Current Liabilities (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Total Current Liabilities came in at $56.0 million in Q1 2026, up 27.65% year-on-year from $43.9 million in Q1 2025, and up 21.83% quarter-over-quarter from $46.0 million in Q4 2025.

Oculis Holding AG (OCS) Total Current Liabilities (2021 - 2026) Analysis & Trends

Oculis Holding AG's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $56.0 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 27.65% year-over-year to $56.0 million in Q1 2026; TTM through Mar 2026 was $56.0 million, a 27.65% increase from a year earlier, with the FY2025 full-year figure at $44.3 million, down 11.85% from the prior year.
  • Total Current Liabilities grew to $56.0 million in Q1 2026 per OCS's latest filing, from $46.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $56.0 million in Q1 2026 and bottomed at $12.5 million in Q4 2022.
  • The 5-year median for Total Current Liabilities is $32.0 million (2024), against an average of $33.8 million.
  • Across the five-year window, Total Current Liabilities surged 183.23% in 2022 and decreased 8.95% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $12.5 million in 2022, then surged by 72.47% to $21.5 million in 2023, then jumped by 134.65% to $50.5 million in 2024, then retreated by 8.95% to $46.0 million in 2025, then climbed by 21.83% to $56.0 million in 2026.
  • Per Business Quant, the three latest OCS Total Current Liabilities figures stand at $56.0 million (Q1 2026), $46.0 million (Q4 2025), and $42.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 56.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 289.60 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 1.35 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 56.01 Mn
Dec 31, 2025 45.98 Mn
Sep 30, 2025 42.16 Mn
Jun 30, 2025 44.14 Mn
Mar 31, 2025 43.88 Mn
Dec 31, 2024 50.50 Mn
Sep 30, 2024 31.99 Mn
Jun 30, 2024 26.13 Mn
Mar 31, 2024 20.80 Mn
Dec 31, 2023 21.52 Mn
Sep 30, 2023 25.08 Mn
Jun 30, 2023 18.69 Mn
Dec 31, 2022 12.48 Mn
Dec 31, 2021 4.41 Mn